Starpharma Holdings Ltd
ASX:SPL
Starpharma Holdings Ltd
Revenue
Starpharma Holdings Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Starpharma Holdings Ltd
ASX:SPL
|
Revenue
AU$10.6m
|
CAGR 3-Years
57%
|
CAGR 5-Years
19%
|
CAGR 10-Years
19%
|
|
Mayne Pharma Group Ltd
ASX:MYX
|
Revenue
AU$190.3m
|
CAGR 3-Years
-25%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
Revenue
AU$237.6m
|
CAGR 3-Years
550%
|
CAGR 5-Years
77%
|
CAGR 10-Years
47%
|
|
Botanix Pharmaceuticals Ltd
ASX:BOT
|
Revenue
AU$588.4k
|
CAGR 3-Years
56%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
Probiotec Ltd
ASX:PBP
|
Revenue
AU$221.2m
|
CAGR 3-Years
28%
|
CAGR 5-Years
24%
|
CAGR 10-Years
13%
|
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
Revenue
AU$11.7m
|
CAGR 3-Years
59%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Starpharma Holdings Ltd's Revenue?
Revenue
10.6m
AUD
Based on the financial report for Dec 31, 2023, Starpharma Holdings Ltd's Revenue amounts to 10.6m AUD.
What is Starpharma Holdings Ltd's Revenue growth rate?
Revenue CAGR 10Y
19%
Over the last year, the Revenue growth was 131%. The average annual Revenue growth rates for Starpharma Holdings Ltd have been 57% over the past three years , 19% over the past five years , and 19% over the past ten years .